Joseph C Wu MD, PhD

Stanford Cardiovascular Institute

Joseph C. Wu, MD, PhD is Director of the Stanford Cardiovascular Institute ( and the Simon H. Stertzer, MD, Professor of Medicine and Radiology. Dr. Wu received his medical degree from Yale. He completed his medicine internship, residency and cardiology fellowship training at UCLA followed by a PhD (Molecular & Medical Pharmacology) in the UCLA STAR program. His clinical activities involve adult congenital heart disease and cardiovascular imaging.

Dr. Wu has published >350 manuscripts. His lab works on biological mechanisms of patient-specific and disease-specific induced pluripotent stem cells (iPSCs). The main goals are to (i) understand cardiovascular disease mechanisms, (ii) accelerate drug discovery, (iii) develop “clinical trial in a dish” concept, and (iv) implement precision medicine for prevention and treatment of cardiovascular patients. His lab uses a combination of genomics, stem cells, cellular & molecular biology, physiological testing, and molecular imaging technologies to better understand molecular and pathological processes.

Dr. Wu has received several awards, including the Burroughs Wellcome Foundation (BWF) Career Award in Medical Sciences, BWF Innovation in Regulatory Science Award, American Heart Association (AHA) Innovative Research Award, AHA Established Investigator Award, AHA Merit Award, National Institute of Health (NIH) Director’s New Innovator Award, NIH Roadmap Transformative Award, and Presidential Early Career Award for Scientists and Engineers (PECASE) given out by President Obama. He is on the editorial board of Journal Clinical Investigation, Circulation Research, Circulation Cardiovascular Imaging, Human Gene Therapy, Molecular Therapy, Stem Cell Research, Physiological Genomics, Scientific Reports, and Nature Review Cardiology.

Dr. Wu is a member of the Association of University Cardiologists (AUC), American Society for Clinical Investigation (ASCI), and Association of American Physicians (AAP). Dr. Wu currently serves on the Scientific Advisory Board for the Keystone Symposia (2014-2020), FDA Cellular, Tissue, and Gene Therapies Advisory Committee (2016-2020), AHA National Board of Directors (2017-2021), Chair of the AHA Research Committee (2017-2021), and Chair of the AHA Basic Cardiovascular Science Council (2018-2020).